Why Synthetic CBD Is (Probably) the Future of Cannabis Pharma
The first company to create and patent a CBD compound will have a serious edge in this fast-growing industry.
Most cannabis producers are busy growing plants, but scientists at biotech companies are actively developing what they believe could be the future of the industry: It's "synthetic" CBD, created in the lab.
Because the synthetic cannabinoid could cut the massive costs of cultivating the crop and quicken the FDA approval process, the quest has taken hold especially among medical marijuana pharmaceutical companies focused on developing new drugs. Already, researchers, universities, and a handful of startups are in the early stages of synthesizing cannabis's CBD. But the first company to actually patent a compound (or the process to make it) in a way that's both therapeutic and scalable would command a serious edge in this fast-growing industry.
4th of July Subscription Sale - Unlock this subscriber exclusive article and more for 20% off today.
Access all Entrepreneur content with no ads, unlock discounts, and get exclusive advice only available to our subscribers. Plus, our magazine delivered straight to your door.
Get 20% off an annual subscription today. Just use code SAVE20 at checkout.